Dishman Pharmaceuticals to raise up to Rs 200 crore through QIP

14 Aug 2014 Evaluate

Dishman Pharmaceuticals & Chemicals has received an approval to raise up to Rs 200 crore by way of issue of shares to Qualified Institutional Investors (QIP), subject to approval of members. The board of directors at its meeting held on August 13, 2014 has approved for the same.

Dishman Pharmaceuticals is engaged in the manufacturing of active pharmaceutical ingredients (APIs) intermediates. The Company operates in two segments: contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats and specialty chemicals.

Peers
Company Name CMP
Sun Pharma Inds. 1720.80
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 902.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×